4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000017
CEO bought 103,500 shares at an average $0.02 ($2,040)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
20 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-03-05 | Purchase : show line 1 in the form | +5,000 | $0.02 | $104 | 21,694,623 | D |
| 2019-03-05 | Purchase : show line 2 in the form | +10,000 | $0.02 | $210 | 21,704,623 | D |
| 2019-03-05 | Purchase : show line 3 in the form | +500 | $0.02 | $10 | 21,705,123 | D |
| 2019-03-05 | Purchase : show line 4 in the form | +15,000 | $0.02 | $311 | 21,720,123 | D |
| 2019-03-05 | Purchase : show line 5 in the form | +1,000 | $0.02 | $21 | 21,721,123 | D |
| 2019-03-06 | Purchase : show line 6 in the form | +5,000 | $0.02 | $93 | 21,726,123 | D |
| 2019-03-06 | Purchase : show line 7 in the form | +10,000 | $0.02 | $188 | 21,736,123 | D |
| 2019-03-06 | Purchase : show line 8 in the form | +500 | $0.02 | $9 | 21,736,623 | D |
| Open-market purchases · 103,500 sh · avg $0.02 · $2,040 | ||||||
Loading xslF345X03/primary_doc.xml…